Most IRB Rules Don’t Ban Finder’s Fees for Clinical Trials

Liz Moench

Mar 3, 2009
by Liz Moench


At first I was getting a bit disheartened by this article until I read the line:

But, they said, reimbursing doctors for the extra time and work involved in recruiting patients and monitoring their involvement in a clinical trial is a murkier area.

I guess the trick is to figure out what a fitting reimbursement payment would be… Enough to be an incentive but not enough to draw suspicion. I feel that the range they gave of $2000 - $10,000 dollars was incredibly rich, though given certain indications could be viewed as a worthwhile investment, but at that point I think an ethical dilemma does come into play. I would not want to find out that my doctor received such a payment for getting me involved in a study… Especially if the study involved a placebo arm of which I may be in.

If the reimbursement was more nominal in nature (though more substantial than I originally anticipated for such a program) and tied to a screening system that tracked activity and could be audited to mitigate risks associated with enrollment solely for profit… And its use was widespread, it could be an excellent recruitment channel.

So what is the magic number?

Read the full article

You must sign-in to add your comment

*Required Fields

  1. Auto-login on future visits


  2. Forgot your password?
    Not a member? submit Register as a new member